Format

Send to

Choose Destination
FEBS Lett. 2011 Jun 6;585(11):1563-7. doi: 10.1016/j.febslet.2011.04.061. Epub 2011 May 7.

Human NK receptors: from the molecules to the therapy of high risk leukemias.

Author information

1
Giannina Gaslini Institute, Genova-Quarto, Italy. lorenzomoretta@ospedale-gaslini.ge.it

Abstract

Natural killer cells are important players of the innate immunity. In humans, they express HLA-class I-specific inhibitory receptors including the allotypic-specific KIR and various activating receptors. In most instances, in an autologous setting NK cells do not kill self cells. In contrast, in an allogeneic setting as the haploidentical hematopoietic stem cell transplantation to cure high risk leukemias, donor-derived NK cells may express inhibitory KIR that are not engaged by the HLA-class I alleles (KIR ligands) expressed by recipient cells. Such "alloreactive" NK cells may be responsible for the eradication of leukemia blasts escaping the preparative regimen, residual host dendritic cells and T lymphocytes, thus preventing leukemia relapse, GvHD and graft rejection, respectively. These NK-mediated effects result in a sharp improvement of the estimated 5 years survival.

PMID:
21554879
DOI:
10.1016/j.febslet.2011.04.061
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center